本頁面由Tiger Trade Technology Pte. Ltd.提供服務

和黃醫藥

14.82
-0.0850-0.57%
成交量:1.04萬
成交額:15.34萬
市值:25.84億
市盈率:146.76
高:14.84
開:14.82
低:14.69
收:14.90
52周最高:16.33
52周最低:9.77
股本:1.74億
流通股本:1.04億
量比:2.17
換手率:0.01%
股息:- -
股息率:- -
每股收益(TTM):0.1010
每股收益(LYR):2.60
淨資產收益率:1.46%
總資產收益率:-1.24%
市淨率:2.05
市盈率(LYR):5.70

資料載入中...

2020/01/21

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/21

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/15

SEC問詢函

CORRESP [Cover] - Correspondence
2020/01/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/20

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/29

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/25

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/17

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/10

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/03

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/30

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/09/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]